Xanthine oxidase activation in chronic heart failure patients with concomitant chronic kidney disease

25 August 2018 (00:00 - 00:00)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Associate Professor Maryna Kolomiiets

Kharkiv National Medical University, Kharkiv (Ukraine)

9 More presentations in this session

Presentation thumbnail

Spectrum of clinical phenotypes and genotypes in 5310 patients with hypertrophic cardiomyopathy

Associate Professor F. Sedaghat-Hamedani (Heidelberg, DE)

Presentation thumbnail

Associations of cachexia and prognosis in patients with heart failure

Doctor E. Ishikawa (Shizuoka, JP)

Presentation thumbnail

Right ventricular function and clinical characteristics of patients with ischemic heart failure, atrial fibrillation and cardiac implantable devices.

Doctor E. Majos-Karwacka (Warsaw, PL)

Presentation thumbnail

Discrepancy in exercise tolerance of optimally treated dilated cardiomyopathy patients with comparable poor LV function

Doctor A. Kar (Kolkata, IN)

Presentation thumbnail

Growth factors and atrophy-related genes are highly expressed in patients with HFpEF and are associated with elevated BNP and reduced exercise capacity and quality of life

Associate Professor T. Bekfani (Magdeburg, DE)

Access the full session

Session thumbnail

Poster Session 5 - Chronic heart failure - Clinical

The Event

ESC Congress 2018

25 August - 29 August 2018

You may be interested in

Congress Presentation

Therapeutic implications of the cardio-renal-metabolic multimorbidity

Congress Presentation

Obesity and inactivity cluster is the strongest predictor of incident heart failure in a population-based study

Congress Presentation

Defining patterns of comorbidity accrual before and after the diagnosis of heart failure

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources